ATRC · AtriCure, Inc.
$44.30
+0.81 (+1.86%)
At close · Aug 14
Market Cap
$2.26B
Shares
50.87M
AtriCure, Inc. Earnings Call Transcripts
Every quarterly earnings call for AtriCure, Inc. (ATRC) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲18.1%
$83.25M
−$12.27M
'22 Q3
22-11-01
▲20.2%
$88.03M
−$4.17M
'22 Q4
23-02-21
▲25.4%
$93.49M
−$6.48M
'23 Q1
23-05-02
▲19.4%
$100.92M
−$5.12M
'23 Q2
23-07-25
▲18.1%
$98.29M
−$9.05M
'23 Q3
23-11-01
▲21%
$106.54M
−$9.79M
'23 Q4
24-01-08
▲16.4%
$108.85M
−$13.27M
'24 Q1
24-05-01
▲15.2%
$116.27M
−$8.01M
'24 Q2
24-07-30
▲17.9%
$115.91M
−$7.85M
'24 Q3
24-10-29
▲16.6%
$124.28M
−$15.57M
'24 Q4
25-02-12
▲13.6%
$123.62M
−$6.75M
'25 Q1
25-04-29
▲17.1%
$136.14M
−$6.19M
'25 Q2
25-07-29
▲15.8%
$134.27M
−$267,000
'25 Q3
25-10-29
▲13.1%
$140.50M
$1.76M
'25 Q4
26-02-17
▲14.3%
$141.25M
$108,000
'26 Q1
26-05-05
LATEST
▲12.8%
$153.60M
$8.96M
'26 Q2
26-07-23
Conference
Investor event
2026-08-11
Canaccord Genuity 46th Annual Growth Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-23
Q2 2026 AtriCure, Inc. Earnings Conference Call
Confident tone
Appendage Management / AtriClip
Pain Management Franchise
Box No AF Clinical Trial
Revenue
$153.60M
▲ 12.8% YoY Diluted EPS
$0.18
Gross margin
77.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-10
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-05
AtriCure, Inc. Q1 FY2026 Earnings Call
Confident tone
BoxX-NoAF Clinical Trial
Pain Management / cryoSPHERE MAX
Appendage Management / AtriClip FLEX-Mini & PRO-Mini
Revenue
$141.25M
▲ 14.3% YoY Diluted EPS
$0.00
Gross margin
77.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-17
AtriCure, Inc. Q4 FY2025 Earnings Call
Confident tone
Financial Performance and Profitability
Afib Ablation / Open Ablation
LeAAPS Clinical Trial
Revenue
$140.50M*
▲ 13.1% YoY Gross margin
75.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-29
AtriCure, Inc. Q3 FY2025 Earnings Call
Confident tone
Appendage Management / AtriClip Growth
Clinical Trials and Market Expansion
Pain Management Franchise Growth
Revenue
$134.27M
▲ 15.8% YoY Diluted EPS
$-0.01
Gross margin
75.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-29
AtriCure, Inc. Q2 FY2025 Earnings Call
Confident tone
Appendage Management (AtriClip franchise)
LeAAPS Clinical Trial
Pain Management / Cryoablation
Revenue
$136.14M
▲ 17.1% YoY Diluted EPS
$-0.13
Gross margin
74.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-29
AtriCure, Inc. Q1 FY2025 Earnings Call
Revenue
$123.62M
▲ 13.6% YoY Diluted EPS
$-0.14
Gross margin
74.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-12
AtriCure, Inc. Q4 FY2024 Earnings Call
Confident tone
Appendage Management / AtriClip
Minimally Invasive / Hybrid AF Pressure from PFA
Pain Management / Cryo Nerve Block
Revenue
$124.28M*
▲ 16.6% YoY Gross margin
74.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-29
AtriCure, Inc. Q3 FY2024 Earnings Call
Confident tone
Hybrid AF Therapy / PFA Competition
Appendage Management / AtriClip
Pain Management Franchise
Revenue
$115.91M
▲ 17.9% YoY Diluted EPS
$-0.17
Gross margin
74.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-30
AtriCure, Inc. Q2 FY2024 Earnings Call
Confident tone
Pain management and CryoSPHERE
AtriClip and appendage management
Hybrid AF therapy and PFA impact
Revenue
$116.27M
▲ 15.2% YoY Diluted EPS
$-0.17
Gross margin
74.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
AtriCure, Inc. Q1 FY2024 Earnings Call
Confident tone
AtriClip / Appendage management franchise
Hybrid AF therapy and PFA complementarity
Innovation and product launches
Revenue
$108.85M
▲ 16.4% YoY Diluted EPS
$-0.28
Gross margin
74.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-08
AtriCure, Inc. Q4 FY2023 Earnings Call
Confident tone
Revenue growth and financial performance
Appendage management (AtriClip)
Hybrid AF therapy / CONVERGE
Revenue
$106.54M*
▲ 21% YoY Gross margin
74.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-01
AtriCure, Inc. Q3 FY2023 Earnings Call
Revenue
$98.29M
▲ 18.1% YoY Diluted EPS
$-0.20
Gross margin
75.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-25
AtriCure, Inc. Q2 FY2023 Earnings Call
Revenue
$100.92M
▲ 19.4% YoY Diluted EPS
$-0.11
Gross margin
76.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
AtriCure, Inc. Q1 FY2023 Earnings Call
Revenue
$93.49M
▲ 25.4% YoY Diluted EPS
$-0.14
Gross margin
74.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-21
AtriCure, Inc. Q4 FY2022 Earnings Call
Revenue
$88.03M*
▲ 20.2% YoY Gross margin
74.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-01
AtriCure, Inc. Q3 FY2022 Earnings Call
Revenue
$83.25M
▲ 18.1% YoY Diluted EPS
$-0.27
▼ 112.8% YoY Gross margin
74.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
AtriCure, Inc. Q2 FY2022 Earnings Call
Revenue
$84.53M
▲ 18.4% YoY Diluted EPS
$-0.32
Gross margin
75.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
AtriCure, Inc. Q1 FY2022 Earnings Call
Revenue
$74.58M
▲ 25.8% YoY Diluted EPS
$-0.33
Gross margin
74.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-10
AtriCure, Inc. Q4 FY2021 Earnings Call
Revenue
$73.22M
▲ 26.8% YoY Gross margin
75.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-03
AtriCure, Inc. Q3 FY2021 Earnings Call
Revenue
$70.46M
▲ 28.7% YoY Diluted EPS
$2.11
Gross margin
74.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
AtriCure, Inc. Q2 FY2021 Earnings Call
Revenue
$71.38M
▲ 74.8% YoY Diluted EPS
$-0.36
Gross margin
75.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-27
AtriCure, Inc. Q1 FY2021 Earnings Call
Revenue
$59.27M
▲ 11.4% YoY Diluted EPS
$-0.38
Gross margin
75.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-11
AtriCure, Inc. Q4 FY2020 Earnings Call
Revenue
$57.73M
▼ 5.9% YoY Gross margin
73.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
AtriCure, Inc. Q3 FY2020 Earnings Call
Revenue
$54.76M
▼ 3.3% YoY Diluted EPS
$-0.11
Gross margin
73.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-28
AtriCure, Inc. Q2 FY2020 Earnings Call
Revenue
$40.82M
▼ 30.7% YoY Gross margin
67.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-29
AtriCure, Inc. Q1 FY2020 Earnings Call
Revenue
$53.23M
▼ 1.4% YoY Gross margin
73.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–28 of 28 earnings calls
Key facts
CIK
1323885
CUSIP
04963C209
13F (30d)
244 filings
242 filers
Visit website
Investor relations